Clopidogrel plus aspirin did not differ from aspirin alone for reducing MI, stroke, and CV death in high risk atherothrombosis: Commentary

Evidence-Based Medicine

Volumn 11, Issue 5, 2006, Pages 143-

  Ballew, Kenneth A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO;

ANGINA PECTORIS; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ATHEROSCLEROSIS; BLEEDING; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SHORT SURVEY; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 33750372332     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.11.5.143     Document Type: Short Survey

References (2)

1. Patrono C, García Rodríguez LA, Landolfi R, et al. N Engl J Med 2005;353:2373-83.
2. Sabatine MS, Cannon CP, Gibson CM, et al. N Engl J Med 2005;352:1179-89.